Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)

  1. Schneeweiss, A.
  2. Chia, S.
  3. Hickish, T.
  4. Harvey, V.
  5. Eniu, A.
  6. Hegg, R.
  7. Tausch, C.
  8. Seo, J.H.
  9. Tsai, Y.-F.
  10. Ratnayake, J.
  11. McNally, V.
  12. Ross, G.
  13. Cortés, J.
Revista:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Any de publicació: 2013

Volum: 24

Número: 9

Pàgines: 2278-2284

Tipus: Article

DOI: 10.1093/ANNONC/MDT182 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus